Table 6 Changes in neuropharmacological parameters compared to group 1 (control) in treatment groups 2, 3 and 4 one hour after administration. Data are given in deviation to normal value.

From: Toxicological testing of allogeneic secretome derived from peripheral mononuclear cells (APOSEC): a novel cell-free therapeutic agent in skin disease

  

Group 2

Group 3

Group 4

Awareness

Alertness

0

−1

−1

Visual placing

0

−4

−4

Passivity

0

+2

+2

Stereotypy

0

0

0

Mood

Grooming

0

−4

−4

Vocalisation

0

0

0

Restlessness

0

0

0

Aggression

0

0

0

Motor activity

Reactivity

0

0

−4

Spontaneous acitvity

0

−1

−2

Touch response

0

−4

−4

Pain response

0

−2

−2

CNS excitation

Startle response

0

0

−2

STRAUB tail

0

0

0

Tremor

0

0

0

Twitching

0

0

0

Convulsion

0

0

0

Posture

Body posture

0

−4

−4

Limb position

0

−4

−4

Staggering gait

0

+2

+2

Abnormal gait

0

0

0

Righting reflex

0

+1

+3

Muscle tone

Limb tone

0

0

0

Grip strength

0

0

0

Body sag

0

0

0

Body tone

0

−1

−2

Abdominal tone

0

−1

−2

Reflexes

Pinna

0

0

−4

Corneal

0

0

0

Ipsilateral Flexor Reflex

0

0

0

Autonomic function

Writhing

0

0

0

Pupil size

0

0

0

Palpebral opening

0

−2

−2

Exophthalmus

0

0

0

Urination

0

0

0

Salivation

0

0

0

Piloerection

0

0

0

Hypothermia

0

0

0

Skin colour

0

0

0

Respiration rate

0

0

0